GB-0895 Clinical Trials (2026): 3 Studies for Severe Asthma & Asthma

Hipa.ai Research · Source: ClinicalTrials.gov / AACT

Synced daily from ClinicalTrials.gov via AACT. Last sync: .

3 GB-0895 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 2 indications (including Severe Asthma & Asthma) and 1,728 total planned enrollment. 2 Phase 3 GB-0895 trials are listed. 2 GB-0895 clinical trials are actively recruiting at 47 U.S. sites across 13 states. Most recent activity: NCT07359846 (Jan 2029).

Where to Participate: All GB-0895 Trial Sites in the U.S. (47 sites across 13 states)

Every actively recruiting GB-0895trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

StateFacilityCityTrialMap
CAResearch Site 13Bakersfield93301NCT07359846Map
CAResearch Site 12Inglewood90301NCT07359846Map
CAResearch Site 23Northridge91324NCT07276724Map
CAResearch Site 26Pasadena91105NCT07276724Map
CAResearch Site 29Rancho Cucamonga91730NCT07276724Map
CAResearch Site 34Valencia91355NCT07276724Map
CAResearch Site 10West Covina91790NCT07359846Map
CAResearch Site 13West Hills91307NCT07276724Map
COResearch Site 15Colorado Springs80923NCT07276724Map
FLResearch Site 32Brooksville34613NCT07276724Map
FLResearch Site 12Doral33122NCT07276724Map
FLResearch Site 14Gainesville32607NCT07276724Map
FLResearch Site 03Hialeah33016NCT07276724Map
FLResearch Site 25Kendall33176NCT07276724Map
FLResearch Site 03Miami33135NCT07359846Map
FLResearch Site 04Miami33126NCT07276724Map
FLResearch Site 06Miami33126NCT07359846Map
FLResearch Site 01Miami Lakes33014NCT07276724Map
FLResearch Site 08North Miami33169NCT07276724Map
FLResearch 09Orlando32807NCT07359846Map
FLResearch Site 10Palm Springs33461NCT07276724Map
FLResearch Site 01Tamarac33321NCT07359846Map
FLResearch Site 02Tampa33613NCT07276724Map
FLResearch Site 04Tampa33607NCT07359846Map
FLResearch Site 05Tampa33617NCT07359846Map
GAResearch Site 18Rincon31326NCT07276724Map
ILResearch Site 31Glenview60026NCT07276724Map
MDResearch Site 16Baltimore21237NCT07276724Map
MDResearch Site 28Columbia21045NCT07276724Map
MDResearch Site 20Towson21204NCT07276724Map
MIResearch Site 06Flint48504NCT07276724Map
MIResearch Site 02Ypsilanti48197NCT07359846Map
MSResearch Site 30Olive Branch38654NCT07276724Map
NCResearch Site 27Gastonia28054NCT07276724Map
OHResearch Site 11Dayton45424NCT07359846Map
TXResearch Site 24Amarillo79106NCT07276724Map
TXResearch Site 19Baytown77521NCT07276724Map
TXResearch Site 07Dallas75230NCT07276724Map
TXResearch Site 17Dallas75254NCT07276724Map
TXResearch Site 09Houston77099NCT07276724Map
TXResearch Site 11Houston77084NCT07276724Map
TXResearch Site 22Kerrville78028NCT07276724Map
TXResearch Site 05Lewisville75057NCT07276724Map
TXResearch Site 33McKinney75069NCT07276724Map
TXResearch Site 07Sugar Land77479NCT07359846Map
UTResearch Site 21Riverton84096NCT07276724Map
VAResearch Site 08Williamsburg23188NCT07359846Map

GB-0895 clinical trials at a glance: phase × recruitment status

Phaserecruitingactive not recruitingTotal
P111
P322

Recruiting GB-0895 clinical trials (2)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

NCT IDTitlePhaseIndicationEnrollmentStarted
NCT07359846SOLAIRIA-2A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)P3Severe Asthma786Jan 2026
NCT07276724SOLAIRIA-1A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)P3Severe Asthma786Dec 2025

GB-0895 clinical trials by indication

Severe Asthma (2)

NCTAcronymPhaseStatusTitle
NCT07359846SOLAIRIA-2P3recruitingA Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
NCT07276724SOLAIRIA-1P3recruitingA Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

Asthma (1)

NCTAcronymPhaseStatusTitle
NCT07116889P1active not recruitingA Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD

GB-0895 pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

AcronymNCTPhaseStatusIndicationEnrollmentPubMed
SOLAIRIA-2NCT07359846P3recruitingSevere Asthma786
SOLAIRIA-1NCT07276724P3recruitingSevere Asthma786

All GB-0895 trials (3)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

NCT IDAcronymTitlePhaseStatusEnrollmentSponsorStarted
NCT07359846SOLAIRIA-2A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)P3recruiting786Generate BiomedicinesJan 2026
NCT07276724SOLAIRIA-1A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)P3recruiting786Generate BiomedicinesDec 2025
NCT07116889A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPDP1active not recruiting156Generate BiomedicinesDec 2023

GB-0895 clinical trials: frequently asked questions

How many GB-0895 clinical trials are there?
3 GB-0895 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 2 are actively recruiting participants.
Are GB-0895 clinical trials recruiting in 2026?
Yes — 2 GB-0895 trials are actively recruiting in 2026, with 47 U.S. sites across 13 states. See the recruiting trials and the per-state site list further down this page.
What conditions is GB-0895 being studied for?
GB-0895 is being studied for Severe Asthma, Asthma, COPD (Chronic Obstructive Pulmonary Disease). The trials are grouped by indication on this page.
What phase is GB-0895 in?
GB-0895 clinical trials span 2 Phase 3, 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
Who sponsors GB-0895 clinical trials?
The lead sponsor across the most GB-0895 trials is Generate Biomedicines. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming GB-0895as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed .

Related pages on Hipa.ai: